ClinChoice Expands Global Presence with Acquisition of CSI in Southeast Asia

ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout Asia, Europe and North America around t...

January 15, 2024 | Monday | News
Fortrea Partners with Veeva and Advarra to Enhance Clinical Trial Experience

Fortrea , a leading global contract research organization (CRO), today announced an industry partnership with founding members Veeva Systems Inc., a l...

January 10, 2024 | Wednesday | News
WuXi Biologics Expanding Manufacturing Capacity in Massachusetts to Meet Growing Demand

he added capacity will further enhance WuXi Biologics’ commercial manufacturing capabilities in the U.S. The site is expected to employ 250 people...

January 08, 2024 | Monday | News
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics

Abzena, the leading end-to-end bioconjugate and complex biologics CDMO has announced a partnership with ProteoNic Biosciences BV, to license their premium ...

December 07, 2023 | Thursday | News
Successful Development and Manufacturing of Complex Biologics with Integrated CMC Solutions

The complexity of new biologics means that these life-changing therapeutics require complicated development and manufacturing processes. Product-specific c...

December 07, 2023 | Thursday | Opinion
Global CDMO, Vetter, Advances Sustainability with Science Based Targets Initiative (SBTi) Membership.

As a result, Vetter has committed to the 1.5 degrees of global warming target. To this end, the CDMO has presented a sustainability strategy with concrete ...

December 06, 2023 | Wednesday | News
Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Test...

November 29, 2023 | Wednesday | News
Samsung Biologics engages suppliers to advance global decarbonization targets

The company invited supplier companies and external ESG specialists to discuss ESG-related requirements and recommendations as well as share successful cas...

November 28, 2023 | Tuesday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
Emergent CEO, Haywood Miller, Highlights Financial Growth and Opioid Crisis Response Efforts as Company Pursues Resilient Future.

Emergent BioSolutions Inc. (NYSE: EBS) today reported selected financial results for the third quarter ended September 30, 2023. The selected financia...

November 09, 2023 | Thursday | Company results
Evonik strengthens its portfolio of nanoparticle technologies and services for parenteral drug delivery

Three block copolymers added to RESOMER® portfolio of bioabsorbable polymers  New nanoparticle process technology increases options for n...

October 25, 2023 | Wednesday | News
Vetter Plans Expansion to Meet Growing Supply Chain Demands

Committed to sustainable growth and long-term planning Dedicated to making investments to support increased customer demand Maintain efficiency a...

October 18, 2023 | Wednesday | News
Samsung Bioepis Presents Phase 1 and 3 Clinical Results for SB16 Biosimilar to Prolia at ASBMR 2023

Phase 1 study for SB16, proposed biosimilar to Prolia, demonstrates pharmacokinetic (PK) bioequivalence between SB16, EU-sourced denosumab, and US-source...

October 16, 2023 | Monday | News
AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facilit...

October 13, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close